Medi Caps Share Price
Sector: Chemical Manufacturing
42.00 -0.05 (-0.12%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
41.00
Today’s High
42.75
52 Week Low
37.23
52 Week High
61.00
Key Metrics
- Market Cap (In Cr) 51.81
- Beta 1.04
- Div. Yield (%) 0
- P/B 0.43
- TTM P/E -
- Sector P/E 0
- Open Price 41.84
- Prev Close 42.05
Medi Caps Analysis
Price Analysis
-
1 Week-2.86%
-
3 Months0.63%
-
6 Month-14.25%
-
YTD-14.32%
-
1 Year-14.63%
Risk Meter
- 44% Low risk
- 44% Moderate risk
- 44% Balanced Risk
- 44% High risk
- 44% Extreme risk
Medi Caps News
How to turn your photos into Chibi figures: step-by-step guide to the trend
1 min read . 24 Apr 2025Conspiracy theories swirl about Blue Origin space mission after door gaffe
3 min read . 16 Apr 2025Medi Caps Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 25.48
- Selling/ General/ Admin Expenses Total
- 8.96
- Depreciation/ Amortization
- 1.72
- Other Operating Expenses Total
- 6.02
- Total Operating Expense
- 29.02
- Operating Income
- -3.55
- Net Income Before Taxes
- -0.84
- Net Income
- -0.57
- Diluted Normalized EPS
- -0.46
- Period
- 2025
- Total Assets
- 125.42
- Total Liabilities
- 4.15
- Total Equity
- 121.28
- Tangible Book Valueper Share Common Eq
- 74.69
- Period
- 2025
- Cashfrom Operating Activities
- 5.07
- Cashfrom Investing Activities
- -4.98
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.09
- Period
- 2024
- Total Revenue
- 27.35
- Selling/ General/ Admin Expenses Total
- 7.07
- Depreciation/ Amortization
- 1.69
- Other Operating Expenses Total
- 10.79
- Total Operating Expense
- 29.07
- Operating Income
- -1.72
- Net Income Before Taxes
- -1.25
- Net Income
- -2.24
- Diluted Normalized EPS
- -1.8
- Period
- 2024
- Total Assets
- 127.28
- Total Liabilities
- 6.3
- Total Equity
- 120.98
- Tangible Book Valueper Share Common Eq
- 74.45
- Period
- 2024
- Cashfrom Operating Activities
- 6.94
- Cashfrom Investing Activities
- -7.73
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.79
- Period
- 2023
- Total Revenue
- 49.37
- Selling/ General/ Admin Expenses Total
- 12.9
- Depreciation/ Amortization
- 1.74
- Other Operating Expenses Total
- 6.34
- Total Operating Expense
- 46.05
- Operating Income
- 3.32
- Net Income Before Taxes
- 4.92
- Net Income
- 1.76
- Diluted Normalized EPS
- 1.5
- Period
- 2023
- Total Assets
- 125.99
- Total Liabilities
- 7.42
- Total Equity
- 118.57
- Tangible Book Valueper Share Common Eq
- 72.52
- Period
- 2023
- Cashfrom Operating Activities
- -6.08
- Cashfrom Investing Activities
- -2.56
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -8.64
- Period
- 2022
- Total Revenue
- 69.87
- Selling/ General/ Admin Expenses Total
- 7.84
- Depreciation/ Amortization
- 1.81
- Other Operating Expenses Total
- 21.97
- Total Operating Expense
- 61.73
- Operating Income
- 8.14
- Net Income Before Taxes
- 10.06
- Net Income
- 10.08
- Diluted Normalized EPS
- 8.01
- Period
- 2022
- Total Assets
- 130.35
- Total Liabilities
- 14.09
- Total Equity
- 116.26
- Tangible Book Valueper Share Common Eq
- 70.66
- Period
- 2022
- Cashfrom Operating Activities
- 7.02
- Cashfrom Investing Activities
- -4.08
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 2.95
- Period
- 2021
- Total Revenue
- 57.42
- Selling/ General/ Admin Expenses Total
- 6.71
- Depreciation/ Amortization
- 1.52
- Other Operating Expenses Total
- 10.47
- Total Operating Expense
- 48.06
- Operating Income
- 9.35
- Net Income Before Taxes
- 11.24
- Net Income
- 11.13
- Diluted Normalized EPS
- 11.14
- Period
- 2021
- Total Assets
- 114.82
- Total Liabilities
- 10.11
- Total Equity
- 104.71
- Tangible Book Valueper Share Common Eq
- 61.4
- Period
- 2021
- Cashfrom Operating Activities
- 15.32
- Cashfrom Investing Activities
- -9.7
- Cashfrom Financing Activities
- -0.06
- Net Changein Cash
- 5.56
- Period
- 2020
- Total Revenue
- 43.05
- Selling/ General/ Admin Expenses Total
- 11.04
- Depreciation/ Amortization
- 1.83
- Other Operating Expenses Total
- 12.05
- Total Operating Expense
- 51.74
- Operating Income
- -8.69
- Net Income Before Taxes
- -5.84
- Net Income
- -5.85
- Diluted Normalized EPS
- -4.69
- Period
- 2020
- Total Assets
- 95.21
- Total Liabilities
- 4.26
- Total Equity
- 90.95
- Tangible Book Valueper Share Common Eq
- 72.94
- Period
- 2020
- Cashfrom Operating Activities
- 4.63
- Cashfrom Investing Activities
- -5.8
- Cashfrom Financing Activities
- -0.06
- Net Changein Cash
- -1.23
- Period
- 2019
- Total Revenue
- 51.78
- Selling/ General/ Admin Expenses Total
- 9.56
- Depreciation/ Amortization
- 1.82
- Other Operating Expenses Total
- 11.27
- Total Operating Expense
- 48.99
- Operating Income
- 2.79
- Net Income Before Taxes
- 5.5
- Net Income
- 5.39
- Diluted Normalized EPS
- 4.32
- Period
- 2019
- Total Assets
- 106.61
- Total Liabilities
- 11.01
- Total Equity
- 95.6
- Tangible Book Valueper Share Common Eq
- 76.67
- Period
- 2019
- Cashfrom Operating Activities
- 5.96
- Cashfrom Investing Activities
- -5.75
- Cashfrom Financing Activities
- -0.05
- Net Changein Cash
- 0.16
- Period
- 2025-03-31
- Total Revenue
- 6.96
- Selling/ General/ Admin Expenses Total
- 2.4
- Depreciation/ Amortization
- 0.44
- Other Operating Expenses Total
- 1.6
- Total Operating Expense
- 7.63
- Operating Income
- -0.67
- Net Income Before Taxes
- 1.45
- Net Income
- 1.72
- Diluted Normalized EPS
- 1.38
- Period
- 2025-03-31
- Total Assets
- 125.42
- Total Liabilities
- 4.15
- Total Equity
- 121.28
- Tangible Book Valueper Share Common Eq
- 74.69
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 5.07
- Cashfrom Investing Activities
- -4.98
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.09
- Period
- 2024-12-31
- Total Revenue
- 4.02
- Selling/ General/ Admin Expenses Total
- 1.95
- Depreciation/ Amortization
- 0.43
- Other Operating Expenses Total
- 1.66
- Total Operating Expense
- 6.23
- Operating Income
- -2.2
- Net Income Before Taxes
- -2.05
- Net Income
- -2.05
- Diluted Normalized EPS
- -1.64
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 8.3
- Selling/ General/ Admin Expenses Total
- 2.5
- Depreciation/ Amortization
- 0.43
- Other Operating Expenses Total
- 0.89
- Total Operating Expense
- 8.27
- Operating Income
- 0.03
- Net Income Before Taxes
- 0.31
- Net Income
- 0.31
- Diluted Normalized EPS
- 0.25
- Period
- 2024-09-30
- Total Assets
- 128.92
- Total Liabilities
- 5.19
- Total Equity
- 123.73
- Tangible Book Valueper Share Common Eq
- 76.65
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 5.52
- Cashfrom Investing Activities
- -4.87
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.66
- Period
- 2024-06-30
- Total Revenue
- 6.19
- Selling/ General/ Admin Expenses Total
- 2.1
- Depreciation/ Amortization
- 0.43
- Other Operating Expenses Total
- 1.87
- Total Operating Expense
- 6.9
- Operating Income
- -0.7
- Net Income Before Taxes
- -0.56
- Net Income
- -0.56
- Diluted Normalized EPS
- -0.45
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 7.87
- Selling/ General/ Admin Expenses Total
- 2.66
- Depreciation/ Amortization
- 0.33
- Other Operating Expenses Total
- 2.61
- Total Operating Expense
- 8.7
- Operating Income
- -0.83
- Net Income Before Taxes
- -0.59
- Net Income
- -1.08
- Diluted Normalized EPS
- -0.87
- Period
- 2024-03-31
- Total Assets
- 127.28
- Total Liabilities
- 6.3
- Total Equity
- 120.98
- Tangible Book Valueper Share Common Eq
- 74.45
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 6.94
- Cashfrom Investing Activities
- -7.73
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.79
- Period
- 2023-12-31
- Total Revenue
- 7.07
- Selling/ General/ Admin Expenses Total
- 2.05
- Depreciation/ Amortization
- 0.45
- Other Operating Expenses Total
- 1.88
- Total Operating Expense
- 6.82
- Operating Income
- 0.25
- Net Income Before Taxes
- 0.34
- Net Income
- -0.16
- Diluted Normalized EPS
- -0.13
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Medi Caps Technical
Moving Average
SMA
- 5 Day42.34
- 10 Day42.69
- 20 Day42.85
- 50 Day43.06
- 100 Day44.51
- 300 Day47.9
Medi Caps Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- The Phosphate Company
- 149.4
- -1.6
- -1.06
- 207.9
- 134.95
- 53.89
- Bhaskar Agrochemicals
- 103.4
- 0
- 0
- 147.65
- 55.25
- 53.87
- Medi Caps
- 42
- -0.05
- -0.12
- 61
- 37.23
- 51.81
- Hardcastle And Waud Mfg Co
- 714.5
- 0
- 0
- 1354.75
- 600
- 48.55
- Camex
- 44.3
- -0.2
- -0.45
- 78.85
- 31.5
- 45.18
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- The Phosphate Company
- 15.56
- 0.61
- 3.84
- 2.72
- Bhaskar Agrochemicals
- 13.82
- 3.03
- 12.7
- 2.29
- Medi Caps
- -
- 0.43
- 3.59
- 8.86
- Hardcastle And Waud Mfg Co
- 37.72
- 1.07
- 3.1
- 27.67
- Camex
- 23.58
- 1.05
- -
- 1.27
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 21-May-25
- Audited Results
- 12-Feb-25
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 07-Aug-24
- Quarterly Results
- 23-May-24
- Quarterly Results
- 08-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- 23-May-23
- Quarterly Results
- 09-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 26-Sept-24
- 07-Aug-24
- AGM
- 29-Sept-23
- 12-Sept-23
- AGM
- 28-Sept-21
- 12-Aug-21
- AGM



